Fatal interstitial lung disease induced by rituximab-containing chemotherapy, treatment with TNF-α antagonist and cytokine profiling: a case-report and review of the literature.
about
Monoclonal antibody therapy and renal transplantation: focus on adverse effectsThe multifaceted aspects of interstitial lung disease in rheumatoid arthritisInhibition of human neutrophil elastase by pentacyclic triterpenesRituximab-associated interstitial lung disease in fibrillary glomerulonephritis.Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin's lymphoma.Early manifestation of mild cognitive impairment in B-cell non-Hodgkin's lymphoma patients receiving CHOP and rituximab-CHOP chemotherapy.
P2860
Fatal interstitial lung disease induced by rituximab-containing chemotherapy, treatment with TNF-α antagonist and cytokine profiling: a case-report and review of the literature.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Fatal interstitial lung diseas ...... and review of the literature.
@en
type
label
Fatal interstitial lung diseas ...... and review of the literature.
@en
prefLabel
Fatal interstitial lung diseas ...... and review of the literature.
@en
P2093
P2860
P356
P1476
Fatal interstitial lung diseas ...... and review of the literature.
@en
P2093
P2860
P304
P356
10.1111/JCPT.12052
P577
2013-03-18T00:00:00Z